Douglas E. Onsi - 26 May 2021 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
CEO,CFO,Pres.,GC,Treas.,&Sec., Director, 10%+ Owner
Signature
/s/ Douglas E. Onsi
Issuer symbol
LPTX
Transactions as of
26 May 2021
Net transactions value
$0
Form type
4
Filing time
28 May 2021, 20:32:32 UTC
Next filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Employee Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 26 May 2021 Common Stock 30,000 $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of May 26, 2021, the Vesting Start Date.